Synergy of IL-23 and Th17 cytokines: new light on inflammatory bowel disease.
about
Role of interleukin-23 circulating levels increase in resected colorectal cancer before and after chemotherapy: preliminary data and future perspectives.Xilei san ameliorates experimental colitis in rats by selectively degrading proinflammatory mediators and promoting mucosal repair.Genetic variants in interleukin genes are associated with breast cancer risk and survival in a genetically admixed population: the Breast Cancer Health Disparities Study.Anti-inflammatory effects of Lactococcus lactis NCDO 2118 during the remission period of chemically induced colitis.Inflammatory tendencies and overproduction of IL-17 in the colon of young NOD mice are counteracted with diet change.Inflammation and gastrointestinal Candida colonizationAssociation of single nucleotide polymorphisms of IL23R and IL17 with ulcerative colitis risk in a Chinese Han population.Animal models of colitis-associated carcinogenesis.Bromodomain coactivators in cancer, obesity, type 2 diabetes, and inflammationImmune responses to HIV in the female reproductive tract, immunologic parallels with the gastrointestinal tract, and research implicationsCharacterization of HCV-specific CD4+Th17 immunity in recurrent hepatitis C-induced liver allograft fibrosis.Longitudinal analysis of inflammation and microbiota dynamics in a model of mild chronic dextran sulfate sodium-induced colitis in mice.Protective effect of royal jelly in 2,4,6 trinitrobenzene sulfonic acid-induced colitis in rats.Interleukin-23-Independent IL-17 Production Regulates Intestinal Epithelial Permeability.Target identification in Fusobacterium nucleatum by subtractive genomics approach and enrichment analysis of host-pathogen protein-protein interactionsNovel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiologyOral Tolerance Induced by OVA Intake Ameliorates TNBS-Induced Colitis in Mice.Interleukin genes and associations with colon and rectal cancer risk and overall survival.Epigallocatechin-3-gallate-induced inhibition of interleukin-6 release and adjustment of the regulatory T/T helper 17 cell balance in the treatment of colitis in miceBerberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironmentExpression of interleukin-22/STAT3 signaling pathway in ulcerative colitis and related carcinogenesis.Plasma Levels of IL-23 and IL-17 before and after Antidepressant Treatment in Patients with Major Depressive Disorder.Cellular and molecular mechanisms in the two major forms of inflammatory bowel disease.Th17 cell cytokine secretion profile in host defense and autoimmunity.Changes of the cytokine profile in inflammatory bowel diseases.Immune activation in irritable bowel syndrome: can neuroimmune interactions explain symptoms?The multifaceted functions of neutrophils.CD169 Expressing Macrophage, a Key Subset in Mesenteric Lymph Nodes Promotes Mucosal Inflammation in Dextran Sulfate Sodium-Induced Colitis.Biological therapy targeting the IL-23/IL-17 axis in inflammatory bowel disease.Interactions between Trichinella spiralis infection and induced colitis in mice.Trans fatty acids exacerbate dextran sodium sulphate-induced colitis by promoting the up-regulation of macrophage-derived proinflammatory cytokines involved in T helper 17 cell polarization.1,4-Dihydroxy-2-naphthoic acid from Propionibacterium freudenreichii reduces inflammation in interleukin-10-deficient mice with colitis by suppressing macrophage-derived proinflammatory cytokines.Intestinal anti-inflammatory activity of Ground Cherry (Physalis angulata L.) standardized CO2 phytopharmaceutical preparation.Members of the novel UBASH3/STS/TULA family of cellular regulators suppress T-cell-driven inflammatory responses in vivo.The impact of mangiferin from Belamcanda chinensis on experimental colitis in rats.Plasma IL-17A levels in patients with late-life depression.Dose-intensified granulocyte-monocyte apheresis in therapy refractory ulcerative colitis.Adsorptive granulocyte/monocyte apheresis use in severe ulcerative colitis and determination of changes in plasma cytokines.Clinical utility of ustekinumab in Crohn's disease.Adoptive transfer of dendritic cells expressing CD11c reduces the immunological response associated with experimental colitis in BALB/c mice.
P2860
Q33814452-D86AD73B-3ADA-4786-A315-A00A635A815BQ33996708-A56524F8-4563-48B1-9C1D-A22FAC1F811DQ34009975-3DCF3350-6EA7-40D0-BF18-9FC83CCB0732Q34018620-ACC15062-76C5-4A94-8F80-A59D3CABCFA5Q34082845-580F9A32-9368-4574-A805-4EFE8BD7362BQ34204874-B261F916-36A4-4CAF-B774-FCCFDC34B19CQ34415858-88948470-3A93-47CE-9C56-33865F530682Q34512820-A3E9ACDA-59E4-4ADD-A605-71437ED36FA6Q34513460-E7C92E61-3445-4C36-AC4D-93EBBB237826Q34712244-28FF9D20-5671-4190-84D6-5F2594879294Q34795394-B0796817-E670-473D-A063-C01F9A4895ABQ35109247-E9BB067B-F230-4211-B7C9-0AF64FCEECCDQ35630469-1339539B-83E3-4614-9DC1-50DE6B6FE972Q35797634-8F2EADC7-2461-479B-A6A9-04CB13E4FCCDQ36017100-6487DE07-F1D6-44DC-8554-0D8934451F7EQ36245600-5929A087-7B9A-4EE7-B3F9-158753299139Q36252781-767FF788-3579-469F-8F31-3F3E590CA033Q36315711-5B365F53-F4A8-43A2-90AC-95D9C1D34121Q36334587-6E6EC6B7-7744-4FB8-B468-D7DEE8947B0AQ36544753-A9295711-BC28-4E70-AD15-F55D4CA55280Q36819589-6D250911-C3B2-4EB3-A687-70E6D7FF4434Q37348823-413D5A2A-0454-4422-BF5F-9DB4E8921672Q37890928-832FD0FC-FAA1-464B-BF7E-15A2E95A0391Q37971256-1E9EBFB1-2980-49FD-B1E5-B1B232643006Q38058782-4D17189C-EA32-4A8D-95F6-2339713748F2Q38104610-97BDD70B-EAE0-42BE-A542-BA168BB7CD10Q38139589-8598B96C-14C0-455E-8B18-5303CDAC3F2CQ38685166-109F200D-AA68-41BC-8ABE-C40A7172A26DQ38798137-EE91BA87-6C46-426F-815E-5FFC8FDBC7C6Q38881720-EA049A3A-18C4-4ECA-82D1-E7735939659AQ39096755-5E9DEDEE-191F-4DFB-9467-0D5AD7990D3FQ39134893-BDFC5316-56C9-4B5F-B9BC-B67F47CD0943Q41024376-8791E1E7-6D56-4E87-B57F-9499725E3A4AQ42673182-F572C00F-57CE-44F0-9ABA-8CBA1139BB86Q43701654-BDC573FA-9199-4B52-8873-FF4B8FCC3B37Q47605434-05D812C8-93A5-42BA-B3F4-B71AC5501776Q48071894-DE866AF5-FAFD-484A-A751-196FE0350B40Q48172718-C11D32C9-CA27-4D79-AA32-BCF3B536C561Q49218809-6134E1AF-7D1A-4303-9979-54E6B18C08DAQ55344717-A7B9F307-0921-4D17-A8CB-677B691E26F0
P2860
Synergy of IL-23 and Th17 cytokines: new light on inflammatory bowel disease.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Synergy of IL-23 and Th17 cytokines: new light on inflammatory bowel disease.
@en
Synergy of IL-23 and Th17 cytokines: new light on inflammatory bowel disease.
@nl
type
label
Synergy of IL-23 and Th17 cytokines: new light on inflammatory bowel disease.
@en
Synergy of IL-23 and Th17 cytokines: new light on inflammatory bowel disease.
@nl
prefLabel
Synergy of IL-23 and Th17 cytokines: new light on inflammatory bowel disease.
@en
Synergy of IL-23 and Th17 cytokines: new light on inflammatory bowel disease.
@nl
P2860
P1476
Synergy of IL-23 and Th17 cytokines: new light on inflammatory bowel disease.
@en
P2093
Scott K Durum
P2860
P2888
P304
P356
10.1007/S11064-009-0091-9
P577
2009-11-14T00:00:00Z